Clinical Trials Logo

Clinical Trial Summary

This study will evaluate the efficacy and safety of atezolizumab compared with placebo as adjuvant therapy after definitive local therapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck (SCCHN)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03452137
Study type Interventional
Source Hoffmann-La Roche
Contact
Status Terminated
Phase Phase 3
Start date April 3, 2018
Completion date March 6, 2024